To investigate whether ESC/STO-GM vaccination elicits CD8 responses, splenocytes from ESC/STO-GM vaccinated and non-vaccinated (control) mice were assessed for in vitro tumor cell killing ten days after immunization. This evidence concerns the gene CD8A and neoplasm.